Positive and negative neuropsychiatric features in Alzheimer's disease.

Positive neuropsychiatric features (paranoia, delusions, hallucinations) and negative features (disinterest/withdrawal, apathy, reduced speech output, reduced physical activity) occur in Alzheimer's disease (AD), although most studies have focused on positive features alone. Positive features may be associated with a more severe and rapidly progressive subtype of AD. A retrospective analysis of prospectively obtained research data (101 probable AD patients) revealed that patients with positive features had been ill longer but were otherwise similar to patients with negative features. Patients with any neuropsychiatric features had more rapid progression and more severe cognitive and comprehension deficits than patients without such features. Neuropsychiatric features in AD likely reflect variations in mesocortical and mesolimbic degeneration rather than an etiologic or prognostic subtype.

[1]  J A Yesavage,et al.  'How far' vs 'how fast' in Alzheimer's disease. The question revisited. , 1994, Archives of neurology.

[2]  D. Jeste,et al.  Cognitive deficits of patients with Alzheimer's disease with and without delusions. , 1992, The American journal of psychiatry.

[3]  R. Mayeux,et al.  Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. , 1991, Archives of neurology.

[4]  J. Becker,et al.  Alzheimer's disease with delusions and hallucinations , 1991, Neurology.

[5]  G. Zubenko,et al.  Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease , 1991, Biological Psychiatry.

[6]  N. Andreasen,et al.  Positive and negative symptoms in schizophrenia. A critical reappraisal. , 1990, Archives of general psychiatry.

[7]  D. Jeste,et al.  Overview of depression and psychosis in Alzheimer's disease. , 1989, The American journal of psychiatry.

[8]  Wayne C. Drevets,et al.  Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type , 1989, Biological Psychiatry.

[9]  D. Weinberger.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.

[10]  R. Oades,et al.  Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity , 1987, Brain Research Reviews.

[11]  Anthony F Jorm.  Subtypes of Alzheimer's Dementia: a conceptual analysis and critical review , 1985, Psychological Medicine.

[12]  R. Mayeux,et al.  Heterogeneity in dementia of the Alzheimer type , 1985, Neurology.

[13]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[14]  P V Rabins,et al.  The impact of dementia on the family. , 1982, JAMA.

[15]  A. Kertesz.  The Western Aphasia Battery , 1982 .

[16]  C. Carter,et al.  Effect of 6‐Hydroxydopamine Lesions of the Medial Prefrontal Cortex on Neurotransmitter Systems in Subcortical Sites in the Rat , 1980, Journal of neurochemistry.

[17]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[18]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[19]  T. McGlashan,et al.  The positive-negative distinction in schizophrenia. Review of natural history validators. , 1992, Archives of general psychiatry.

[20]  P. Rabins,et al.  Management of behavior disturbance in Alzheimer disease: current knowledge and future directions. , 1992, Alzheimer disease and associated disorders.

[21]  J. Cummings,et al.  Noncognitive neuropsychiatric syndromes in alzheimer’s disease , 1990 .

[22]  N. Andreasen.  Positive vs. negative schizophrenia: a critical evaluation. , 1985, Schizophrenia bulletin.